Ruijin Hospital: Neoplasms trials

The registry lists 12 Neoplasms studies with Ruijin Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric CancerRecruitingNCT07366528Phase 3
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal MalignanciesRecruitingNCT06644274
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary MalignancyRecruitingNCT06597539
• A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver MetastasesRecruitingNCT06567353Not applicable
• Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid TumorsRecruitingNCT05916248Early Phase 1
• Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung CancerRecruitingNCT04973293Not applicable
• Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors PatientsStatus unknownNCT05097781Phase 2
• Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLCActive, not recruitingNCT04945928Not applicable
• Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 MutationStatus unknownNCT04869475Phase 2
• Airway Segmented Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Distal BronchiStatus unknownNCT03890575Not applicable
• Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDSStatus unknownNCT03855371Phase 1
• Single-incision Versus Conventional Laparoscopic Surgery for Colorectal CancerWithdrawnNCT03633539Not applicable